These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36037222)

  • 21. SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains.
    Radvak P; Kwon HJ; Kosikova M; Ortega-Rodriguez U; Xiang R; Phue JN; Shen RF; Rozzelle J; Kapoor N; Rabara T; Fairman J; Xie H
    Nat Commun; 2021 Nov; 12(1):6559. PubMed ID: 34772941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microglia Do Not Restrict SARS-CoV-2 Replication following Infection of the Central Nervous System of K18-Human ACE2 Transgenic Mice.
    Olivarria GM; Cheng Y; Furman S; Pachow C; Hohsfield LA; Smith-Geater C; Miramontes R; Wu J; Burns MS; Tsourmas KI; Stocksdale J; Manlapaz C; Yong WH; Teijaro J; Edwards R; Green KN; Thompson LM; Lane TE
    J Virol; 2022 Feb; 96(4):e0196921. PubMed ID: 34935438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research.
    Dedoni S; Avdoshina V; Camoglio C; Siddi C; Fratta W; Scherma M; Fadda P
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Animal Models of COVID-19: Transgenic Mouse Model.
    Park JG; Pino PA; Akhter A; Alvarez X; Torrelles JB; Martinez-Sobrido L
    Methods Mol Biol; 2022; 2452():259-289. PubMed ID: 35554912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of Three Variants of SARS-CoV-2 In Vivo Shows Host-Dependent Pathogenicity in Hamsters, While Not in K18-hACE2 Mice.
    Toomer G; Burns W; Garcia L; Henry G; Biancofiori A; George A; Duffy C; Chu J; Sides M; Muñoz M; Garcia K; Nikolai-Yogerst A; Peng X; Westfall L; Baker R
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early pathogenesis profiles across SARS-CoV-2 variants in K18-hACE2 mice revealed differential triggers of lung damages.
    Aw ZQ; Mok CK; Wong YH; Chen H; Mak TM; Lin RTP; Lye DC; Tan KS; Chu JJH
    Front Immunol; 2022; 13():950666. PubMed ID: 36389747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutting Edge: Characterization of Low Copy Number Human Angiotensin-Converting Enzyme 2-Transgenic Mice as an Improved Model of SARS-CoV-2 Infection.
    Bradshaw CM; Georgieva T; Tankersley TN; Taylor-Doyle T; Johnson L; Uhrlaub JL; Besselsen D; Nikolich JŽ
    J Immunol; 2024 Feb; 212(4):523-528. PubMed ID: 38197714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 variants of concern elicit divergent early immune responses in hACE2 transgenic mice.
    Fricke C; Pfaff F; Ulrich L; Halwe NJ; Schön J; Timm L; Hoffmann W; Rauch S; Petsch B; Hoffmann D; Beer M; Corleis B; Dorhoi A
    Eur J Immunol; 2023 Dec; 53(12):e2250332. PubMed ID: 37609807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. K18-hACE2 mice develop respiratory disease resembling severe COVID-19.
    Yinda CK; Port JR; Bushmaker T; Offei Owusu I; Purushotham JN; Avanzato VA; Fischer RJ; Schulz JE; Holbrook MG; Hebner MJ; Rosenke R; Thomas T; Marzi A; Best SM; de Wit E; Shaia C; van Doremalen N; Munster VJ
    PLoS Pathog; 2021 Jan; 17(1):e1009195. PubMed ID: 33465158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological and Pathological Peculiarity of Severe Acute Respiratory Syndrome Coronavirus 2 Beta Variant.
    Lee S; Yoon GY; Lee SJ; Kwon YC; Moon HW; Kim YJ; Kim H; Lee W; Jeong GU; Kim C; Kim KD; Kim SJ; Ahn DG
    Microbiol Spectr; 2022 Oct; 10(5):e0237122. PubMed ID: 36005818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delta (B1.617.2) variant of SARS-CoV-2 induces severe neurotropic patterns in K18-hACE2 mice.
    Yang JH; Yang MS; Kim DM; Kim B; Tark D; Kang SM; Lee GH
    Sci Rep; 2023 Feb; 13(1):3303. PubMed ID: 36849513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BSL2-compliant lethal mouse model of SARS-CoV-2 and variants of concern to evaluate therapeutics targeting the Spike protein.
    Manangeeswaran M; Ireland DDC; Thacker SG; Lee HN; Kelley-Baker L; Lewkowicz AP; Rothlauf PW; Cornejo Pontelli M; Bloyet LM; Eckhaus MA; Mendoza MI; Whelan S; Verthelyi D
    Front Immunol; 2022; 13():919815. PubMed ID: 35967447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cell-adapted SARS-CoV-2 mutant, showing a deletion in the spike protein spanning the furin cleavage site, has reduced virulence at the lung level in K18-hACE2 mice.
    Valleriani F; Di Pancrazio C; Spedicato M; Di Teodoro G; Malatesta D; Petrova T; Profeta F; Colaianni ML; Berjaoui S; Puglia I; Caporale M; Rossi E; Marcacci M; Luciani M; Sacchini F; Portanti O; Bencivenga F; Decaro N; Bonfante F; Lorusso A
    Virology; 2024 Apr; 592():109997. PubMed ID: 38324940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fatal Neurodissemination and SARS-CoV-2 Tropism in K18-hACE2 Mice Is Only Partially Dependent on hACE2 Expression.
    Carossino M; Kenney D; O'Connell AK; Montanaro P; Tseng AE; Gertje HP; Grosz KA; Ericsson M; Huber BR; Kurnick SA; Subramaniam S; Kirkland TA; Walker JR; Francis KP; Klose AD; Paragas N; Bosmann M; Saeed M; Balasuriya UBR; Douam F; Crossland NA
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35336942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2.
    Sánchez-Morales L; Porras N; García-Seco T; Pérez-Sancho M; Cruz F; Chinchilla B; Barroso-Arévalo S; Diaz-Frutos M; Buendía A; Moreno I; Briones V; Risalde MLÁ; de la Fuente J; Juste R; Garrido J; Balseiro A; Gortázar C; Rodríguez-Bertos A; Domínguez M; Domínguez L
    Vet Res; 2024 May; 55(1):71. PubMed ID: 38822398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transgenic mouse models support a protective role of type I IFN response in SARS-CoV-2 infection-related lung immunopathology and neuroinvasion.
    Chauhan NR; Kundu S; Bal R; Chattopadhyay D; Sahu R; Mehto S; Yadav R; Krishna S; Jena KK; Satapathy S; Pv A; Murmu KC; Singh B; Patnaik S; Jena S; Harshan KH; Syed GH; Idris MM; Prasad P; Chauhan S
    Cell Rep; 2023 Nov; 42(11):113275. PubMed ID: 37874678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.
    Kim SH; Kim J; Jang JY; Noh H; Park J; Jeong H; Jeon D; Uhm C; Oh H; Cho K; Jeon Y; On D; Yoon S; Lim SY; Kim SP; Lee YW; Jang HJ; Park IH; Oh J; Seo JS; Kim JJ; Seok SH; Lee YJ; Hong SM; An SH; Kim SY; Kim YB; Hwang JY; Lee HJ; Kim HB; Choi KS; Park JW; Seo JY; Yun JW; Shin JS; Lee HY; Kim K; Lee D; Lee H; Nam KT; Seong JK
    Front Immunol; 2022; 13():1055811. PubMed ID: 36457995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2.
    Golden JW; Li R; Cline CR; Zeng X; Mucker EM; Fuentes-Lao AJ; Spik KW; Williams JA; Twenhafel N; Davis N; Moore JL; Stevens S; Blue E; Garrison AR; Larson DD; Stewart R; Kunzler M; Liu Y; Wang Z; Hooper JW
    mBio; 2022 Feb; 13(1):e0290621. PubMed ID: 35073750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant.
    Chang YC; Yang CF; Chen YF; Yang CC; Chou YL; Chou HW; Chang TY; Chao TL; Hsu SC; Ieong SM; Tsai YM; Liu PC; Chin YF; Fang JT; Kao HC; Lu HY; Chang JY; Weng RS; Tu QW; Chang FY; Huang KY; Lee TY; Chang SY; Yang PC
    EMBO Mol Med; 2022 Apr; 14(4):e15298. PubMed ID: 35138028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.